AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

SymbolPriceChange %Market CapVolume
MRNA $33.32 -1.45% $14.18B 6,295,489
PACB $1.25 -1.57% $378.47M 2,445,313
BNTX $102.66 -8.71% $24.88B 2,075,144
FLGT $22.27 1.46% $672.79M 166,995
CRSP $54.10 -1.39% $4.82B 1,500,102
ILMN $98.18 -0.76% $15.21B 1,075,555
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.